Dr. Susanne Arnold, MD
Claim this profileUniversity of Kentucky/Markey Cancer Center
Area of expertise
Lung Cancer
Susanne Arnold, MD has run 16 trials for Lung Cancer. Some of their research focus areas include:
Non-Small Cell Lung Cancer
Susanne Arnold, MD has run 14 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
University Of Kentucky/Markey Cancer Center
University Of Kentucky
Clinical Trials Susanne Arnold, MD is currently running
EP0031
for Cancer
The aim of this study is to assess the safety, side effects and effectiveness of EP0031 in patients with advanced RET-altered malignancies (NSCLC)
Recruiting
1 award
Phase 1 & 2
Pembrolizumab + Radiation vs Chemotherapy + Radiation
for Head and Neck Cancer
This phase II trial studies the effect of pembrolizumab alone compared to the usual approach (chemotherapy \[cisplatin and carboplatin\] plus radiation therapy) after surgery in treating patients with head and neck squamous cell carcinoma that has come back (recurrent) or patients with a second head and neck cancer that is not from metastasis (primary). Radiation therapy uses high energy radiation or protons to kill tumor cells and shrink tumors. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of cancer cells. Carboplatin is also in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer and may interfere with the ability of tumor cells to grow and spread. Giving pembrolizumab alone after surgery may work better than the usual approach in shrinking recurrent or primary head and neck squamous cell carcinoma.
Recruiting
1 award
Phase 2
31 criteria
More about Susanne Arnold, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 39 trials as a Principal Investigator · 14 Active Clinical Trials
Treatments Susanne Arnold, MD has experience with
- Pembrolizumab
- Cisplatin
- Ipatasertib
- Binimetinib
- Paclitaxel
- Carboplatin
Breakdown of trials Susanne Arnold, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Susanne Arnold, MD specialize in?
Susanne Arnold, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Susanne Arnold, MD currently recruiting for clinical trials?
Yes, Susanne Arnold, MD is currently recruiting for 14 clinical trials in Lexington Kentucky. If you're interested in participating, you should apply.
Are there any treatments that Susanne Arnold, MD has studied deeply?
Yes, Susanne Arnold, MD has studied treatments such as Pembrolizumab, Cisplatin, Ipatasertib.
What is the best way to schedule an appointment with Susanne Arnold, MD?
Apply for one of the trials that Susanne Arnold, MD is conducting.
What is the office address of Susanne Arnold, MD?
The office of Susanne Arnold, MD is located at: University of Kentucky/Markey Cancer Center, Lexington, Kentucky 40536 United States. This is the address for their practice at the University of Kentucky/Markey Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.